selected publications
-
academic article
- Altered Balance of Reelin Proteolytic Fragments in the Cerebrospinal Fluid of Alzheimer's Disease Patients. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 1-16. 2022
- Apolipoprotein E imbalance in the cerebrospinal fluid of Alzheimer's disease patients. ALZHEIMERS RESEARCH & THERAPY. 1-19. 2022
- Serum Angiotensin-Converting Enzyme 2 as a Potential Biomarker for SARS-CoV-2 Infection and Vaccine Efficacy. FRONTIERS IN IMMUNOLOGY. 1-10. 2022
- The apolipoprotein receptor LRP3 compromises APP levels. ALZHEIMERS RESEARCH & THERAPY. 1-17. 2021
-
congress communication
- Deciphering ACE2 and TMPRSS2 changes in Down syndrome and Alzheimer's dementia: concerns regarding COVID-19 2024
- Apolipoprotein E imbalance in the cerebrospinal fluid of Alzheimer¿s disease patients 2022
- Apolipoprotein E imbalance in the cerebrospinal fluid of Alzheimer¿s disease patients 2022
- Apolipoprotein E species are altered in the cerebrospinal fluid of patients with the Alzheimer¿s disease 2022
- CSF Apolipoprotein E characterization in Alzheimer¿s disease 2022
- THE EXPRESSION OF THE LIPOPROTEIN RECEPTOR LRP3 IS INDUCED BY APOER2/REELIN AND IT IS ABLE TO REGULATEAPP 2022
- Apolipoprotein E CSF levels are altered in Alzheimer's Disease 2021
- The apolipoprotein receptor LRP3 is regulated by ApoER2/reelin signalling and controls APP expression 2021
-
thesis